ALiA BioTech’s One-stop Diagnostic Platform Brings Multiplex Testing to the Medical Front Line
ALiA BioTech is ready to deploy a rapid diagnostic platform that can conduct multiplex testing in a single biochip within 15 minutes.
Read MorePosted by Andy Lundin | Jan 18, 2023 | Diagnostic Technologies |
ALiA BioTech is ready to deploy a rapid diagnostic platform that can conduct multiplex testing in a single biochip within 15 minutes.
Read MorePosted by Andy Lundin | Dec 13, 2022 | Unknown Origin & Other Cancer Types |
A new study revealed a breakthrough hand-held biosensor that enables quick and accurate detection of oral cancer.
Read MorePosted by Chris Wolski | Oct 6, 2022 | Sexually Transmitted Diseases |
Laboratories are well-positioned to meet STI testing demands during the current surge of sexually transmitted diseases in the U.S.
Read MorePosted by Chris Wolski | Oct 4, 2022 | Emerging & Zoonotic Diseases, Sexually Transmitted Diseases |
With demand for monkeypox testing, labs will need to be aware of the regulations related to coding, reimbursement, and compliance issues.
Read MorePosted by Andy Lundin | Sep 8, 2022 | Emerging & Zoonotic Diseases |
The FDA is taking steps to increase monkeypox testing capacity and accessibility nationwide as part of its commitment to address the outbreak.
Read More